Мобильная версия

Доступно журналов:

3 288

Доступно статей:

3 891 637

 

Скрыть метаданые

Автор Sweeney, Dwight, P.
Автор Forness, Steven, R.
Автор Levitt, Jennifer, G.
Дата выпуска 1998
dc.description There are 10 major classes of medications that have been used to treat children who display learning or behavioral disorders associated with autism, Tourette syndrome, or pervasive developmental disorders (PDD). These include stimulant medications, antidepressants, antihypertensives, anticonvulsants, antipsychotics, anxiolytics, antihistamines, narcotic antagonists, beta blockers, and serotonin antagonists. It has been estimated that between 15% and 20% of children in special education may be receiving one or more of these drugs. This article discusses the potential uses of psychopharmarcologic therapy with children or adolescents who are diagnosed with autism, Tourette syndrome, or PDD and who display learning, emotional, or behavioral disorders. It explores the possible benefits and known negative side effects associated with such treatment.
Издатель SAGE Publications
Название An Overview of Medications Commonly Used to Treat Behavioral Disorders Associated with Autism, Tourette Syndrome, and Pervasive Developmental Disorders
Тип Journal Article
DOI 10.1177/108835769801300302
Electronic ISSN 1538-4829
Print ISSN 1088-3576
Журнал Focus on Autism and Other Developmental Disabilities
Том 13
Первая страница 144
Последняя страница 150
Аффилиация Sweeney, Dwight, P., Dwight P. Sweeney, PhD, is a professor of educational psychology and counseling and director of the University Center for Developmental Disabilities, California State University, San Bernardino. Address: Dwight P. Sweeney, Department of Educational Psychology and Counseling, California State University, 5500 University Parkway, San Bernardino, CA 92407–2397.
Аффилиация Forness, Steven, R., Steven R. Forness, EdD, is a professor of psychiatry and biobehavioral science and principal of the Inpatient School, UCLA Neuropsychiatric Hospital.
Аффилиация Levitt, Jennifer, G., Jennifer G. Levitt, MD, is an assistant professor of psychiatry and biobehavioral sciences, UCLA Neuropsychiatric Hospital.
Выпуск 3
Библиографическая ссылка Aman, M. G., & Wolford, P. L. (1995). Consumer satisfaction with involvement in drug research: A social validity study. Journal of the American Academy of Child and Adolescent Psychiatry, 34(7), 940–945.
Библиографическая ссылка Baldessarini, R. J., & Teicher, M. H. (1995). Dosing of antipsychotic agents in pediatric populations. Journal of Child and Adolescent Psychopharmacology, 5(1), 1–4.
Библиографическая ссылка Barkley, R. A. (1990). Hyperactive children: A handbook for diagnosis and treatment. New York: Guilford Press.
Библиографическая ссылка Bastianens, L., & Bastianens, D. K. (1993). A manual of psychiatric medications for teenagers. Journal of Child and Adolescent Psychopharmacology, 3, 175, M1–M59.
Библиографическая ссылка Biederman, J. (1996). Introduction: Contemporary perspectives on pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 34(10), 1274–1275.
Библиографическая ссылка Campbell, M., Anderson, L. T., & Small, A. M. (1990). Naltrexone in autistic children: A double-blind and placebo-controlled study. Psychopharmacology Bulletin, 26(1), 130–135.
Библиографическая ссылка Campbell, M., & Cueva, J. E. (1995). Psychopharmacology in child and adolescent psychiatry: A review of the past seven years. Part II. Journal of the American Academy of Child and Adolescent Psychiatry, 34(10), 1262–1271.
Библиографическая ссылка Fleck, S. (1995). Dehumanizing developments in American psychiatry in recent decades. Journal of Nervous and Mental Disease, 183, 195–203.
Библиографическая ссылка Forness, S. R., Swanson, J. M., Cantwell, D. P., Guthrie, D., & Sena, R. (1992). Response to stimulant medication across six measures of school-related performance in children with ADHD and disruptive behavior. Behavioral Disorders, 18, 42–53.
Библиографическая ссылка Forness, S. R., Sweeney, D. P., & Toy, K. (1996). Psychopharmacologic medication: What teachers need to know. Beyond Behavior, 7(2), 4–11.
Библиографическая ссылка Gadow, K. D. (1992). Pediatric psychopharmacology: A review of recent research. Journal of Child Psychology and Psychiatry, 33, 153–195.
Библиографическая ссылка Glantz, L. H. (1996). Conducting research with children: Legal and ethical issues. Journal of the American Academy of Child and Adolescent Psychiatry, 34(10), 1283–1291.
Библиографическая ссылка Greenhill, L. L., Abikoff, H. B., Arnold, E., Cantwell, D. P., Conners, C. K., Elliott, G., Hechtman, L., Hinshaw, S. P., Hoza, B., Jensen, P. S., March, J. S., Newcorn, J., Pelham, W. E., Severe, J. B., Swanson, J. M., Vitiello, B., & Wells, K. (1996). Medication treatment strategies in the MTA study: Relevance to clinicians and researchers. Journal of the American Academy of Child and Adolescent Psychiatry, 34(10), 1304–1313.
Библиографическая ссылка Hallfors, D., Watson, K., & Fallon, T. (1995). An examination of psychotropic drug treatment for children with serious emotional disturbances. Waltham, MA: Brandeis University, Heller School, Family and Childrenʼs Policy Center.
Библиографическая ссылка Hunt, R. D., Capper, L., & OʼConnell, P. (1990). Clonidine in child and adolescent psychiatry. Journal of Child and Adolescent Psychopharmacology, 1(1), 87–101.
Библиографическая ссылка Kaplan, S. L., Simms, R. M., & Busner, J. (1994). Prescribing practices of outpatient child psychiatrists. Journal of the American Academy of Child and Adolescent Psychiatry, 33(1), 35–44.
Библиографическая ссылка Keltner, N. L., & Folks, D. G. (1993). Psychotropic drugs. St. Louis: Mosby.
Библиографическая ссылка Konopasek, D. E. (1998). Medication “Fact Sheets”: A medication reference guide for the non-medical professional. Anchorage, AK: Arctic Tern Publishing Co. (Available from Dean E. Konopasek, P.O. Box 111994, Anchorage, AK 99511--1994.)
Библиографическая ссылка Laughren, T. P. (1996). Regulatory issues in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 34(10), 1276–1282.
Библиографическая ссылка Lewis, M. H. (1996). Brief report: Psycho pharmacology of autism spectrum disorder. Journal of Autism and Developmental Disorders, 26, 231–235.
Библиографическая ссылка McClellan, J., & Werry, J. (1994). Practice parameters for assessment and treatment of children and adolescents with schizophrenia. Journal of the American Academy of Child and Adolescent Psychiatry, 33(5), 616–635.
Библиографическая ссылка McDougle, C. J., Naylor, S. T., Cohen, D. J., Volkmar, F. R., Heninger, G. R., & Price, L. H. (1996). A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Archives of General Psychiatry, 53, 1001–1008.
Библиографическая ссылка McDougle, C. J., Price, L. H., & Volkmar, F. R. (1994). Recent advances in the pharmacotherapy of autism and related conditions. Child and Adolescent Psychiatric Clinics of North America, 3, 71–89.
Библиографическая ссылка Pelham, W. E., Swanson, J. M., Furman, M. B., & Schwindt, H. (1995). Pemoline effects on children with ADHD: A time-response by dose-response analysis on classroom measures. Journal of the American Academy of Child and Adolescent Psychiatry, 34(11), 1504–1513.
Библиографическая ссылка Popper, C. W. (1987). Medical unknowns and ethical consent: Prescribing psychotropic medications for children in the face of uncertainty. In C. W. Popper (Ed.), Psychiatric pharmacosciences of children and adolescents (pp. 212–221). Washington, DC: American Psychiatric Press.
Библиографическая ссылка Resources in Special Education (RiSE). (1997, January). Best practices for designing and delivering effective programs for individuals with autistic spectrum disorder: Recommendations of the collaborative work group on autistic spectrum disorder. Sacramento: California Department of Education.
Библиографическая ссылка Rimland, B., Callaway, E., & Dreyfus, P. (1978). The effect of high doses of vitamin B6 on autistic children: A double-blind crossover study. American Journal of Psychiatry, 135, 472–475.
Библиографическая ссылка The Robert Wood Johnson Foundation, Harvard School of Public Health, & Louis Harris and Associates. (1995). Sick people in managed care have difficulty getting services and treatment. Medical Benefits, 12(16), 6–7.
Библиографическая ссылка Rosenberg, D. R., Holttum, J., & Gershon, S. (1994). Textbook of pharmacotherapy for child and adolescent psychiatric disorders. New York: Brunner/Mazel.
Библиографическая ссылка Smalley, S. L., Levitt, J. G., & Bauman, M. (in press). In C. E. Coffey & R. A. Brumback (Eds.), Textbook of pediatric neuropsychiatry. Washington, DC: American Psychiatric Press.
Библиографическая ссылка Swanson, J. M., Flockhart, D., Udrea, D., Cantwell, D., Connor, D., & Williams, L. (1995). Clonidine in the treatment of ADHD: Questions about safety and efficacy. Journal of Child and Adolescent Psychopharmacology, 5(4), 301–304.
Библиографическая ссылка Sweeney, D. P., Forness, S. R., Kavale, K. A., & Levitt, J. G. (1997). An update on psychopharmacologic medication: What teachers, clinicians, and parents need to know. Intervention in School and Clinic, 33(1), 4–21, 25.
Библиографическая ссылка Werkman, S. (1993). The role of medication in treatment of childhood depression. Journal of Child and Adolescent Psychopharmacology, 5(1), 13–27.
Библиографическая ссылка Wilens, T. E., Spencer, T., Biederman, J., Wozniak, J., & Connor, D. (1995). Combined pharmacotherapy: An emerging trend in pediatric psychopharmacology. Journal of the American Academy of Child and Adolescent Psychiatry, 34(1), 110–112.

Скрыть метаданые